311 – 320 of 344
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
The Human Protein Atlas - a tool for pathology
(
- Contribution to journal › Letter
-
Mark
15-Prostaglandin Dehydrogenase Expression Alone or in Combination with ACSM1 Defines a Subgroup of the Apocrine Molecular Subtype of Breast Carcinoma
(
- Contribution to journal › Article
-
Mark
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Epidermal growth factor receptor expression in 334 non small cell lung carcinoma patients; prognosis and correlation between gene copy number and protein expression
2008) 3rd Intercontinental Congress of Pathology In Virchows Archiv: an international journal of pathology 452(Suppl. 1). p.3-3(
- Contribution to journal › Published meeting abstract
-
Mark
Oestrogen receptor beta immunohistochemistry: time to get it right? Authors' response
(
- Contribution to journal › Letter
-
Mark
Sox11, a non-B cell lineage transcription factor, is overexpressed in mantle cell lymphoma
2008) 10th International Conference on Malignant Lymphoma In Annals of Oncology 19(Suppl. 4). p.172-173(
- Contribution to journal › Published meeting abstract
-
Mark
Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern.
(
- Contribution to journal › Article
-
Mark
Systematic validation of novel breast cancer progression-associated biomarkers via high-throughput antibody generation and application of tissue microarray technology
2008) EBCC-6, European Breast Cancer Conference, 2008 In European Journal of Cancer Supplements 6(7). p.59-59(
- Contribution to journal › Published meeting abstract
-
Mark
HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors.
(
- Contribution to journal › Article
-
Mark
Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
(
- Contribution to journal › Article